In a 45-year-old man with severe sepsis from multifocal pneumonia, who is intubated, hypotensive on vasopressors, anuric, volume overloaded, hyperkalemic, and acidotic with markedly elevated creatinine and BUN, what is the preferred renal replacement therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Continuous Renal Replacement Therapy (CRRT)

In this hemodynamically unstable septic patient with anuria, severe volume overload, life-threatening hyperkalemia (K+ 5.9), and metabolic acidosis (bicarb 10), initiate continuous renal replacement therapy (CRRT) immediately.

Clinical Reasoning

This patient presents with multiple absolute indications for urgent dialysis:

  • Anuria with worsening volume overload causing respiratory compromise (requiring FiO2 0.8)
  • Severe hyperkalemia (5.9 mEq/L) - immediate life-threatening arrhythmia risk
  • Severe metabolic acidosis (bicarbonate 10 mEq/L)
  • Uremia (BUN 112, creatinine 6.5)
  • Hemodynamic instability (BP 85/50 on vasopressors)

The Surviving Sepsis Campaign guidelines explicitly address this scenario 1:

Why CRRT Over Other Options:

CRRT is specifically recommended for hemodynamically unstable septic patients to facilitate fluid balance management 1. While the guidelines state that continuous and intermittent RRT are equivalent in terms of mortality, they make a weak recommendation with very low quality evidence to use continuous therapies specifically for hemodynamically unstable patients 1.

Why NOT the Other Options:

  1. Furosemide infusion (#1): Completely inappropriate. This patient is anuric - loop diuretics require functioning tubules to work. Attempting diuresis in established anuric AKI wastes critical time while life-threatening hyperkalemia and acidosis worsen.

  2. Intermittent hemodialysis (#2): While equivalent to CRRT for mortality in stable patients 1, intermittent HD causes rapid fluid and solute shifts that can precipitate hemodynamic collapse in vasopressor-dependent patients. This patient's BP is already 85/50 on pressors - the rapid ultrafiltration and osmotic shifts of intermittent HD would likely cause cardiovascular decompensation.

  3. Bicarbonate replacement (#3): The guidelines explicitly recommend against sodium bicarbonate therapy for improving hemodynamics or reducing vasopressor requirements when pH ≥ 7.15 1. While we don't have the exact pH, the bicarbonate of 10 with ongoing sepsis suggests the acidosis is multifactorial (lactic acidosis from septic shock plus uremic acidosis). Bicarbonate administration would:

    • Add significant sodium and volume load to an already volume-overloaded patient
    • Not address the underlying renal failure
    • Not treat the hyperkalemia
    • Not remove uremic toxins
    • Potentially worsen intracellular acidosis through CO2 generation

CRRT Implementation Strategy

Initiate CRRT with the following approach:

  • Modality: Continuous venovenous hemofiltration (CVVH) or hemodiafiltration (CVVHDF)
  • Vascular access: Large-bore dialysis catheter (avoid femoral if possible due to infection risk)
  • Anticoagulation: Regional citrate if no contraindications; otherwise heparin-free given bleeding risk in sepsis
  • Ultrafiltration rate: Start conservatively (100-200 mL/hr net removal) given hypotension
  • Dialysate/replacement fluid: Adjust potassium-free initially given K+ 5.9

Immediate Concurrent Management:

While preparing CRRT (which may take 30-60 minutes to initiate):

  • For hyperkalemia temporization:

    • Calcium gluconate 1-2 grams IV (cardiac membrane stabilization)
    • Regular insulin 10 units + dextrose 50 grams IV (intracellular K+ shift)
    • Consider nebulized albuterol (additional K+ shift)
  • Continue aggressive sepsis management: Antibiotics, vasopressor titration, source control

Critical Pitfalls to Avoid

  1. Delaying dialysis to "try diuretics first" - This patient is anuric; diuretics will not work and delay definitive therapy

  2. Choosing intermittent HD because "it's faster" - The rapid solute/fluid shifts will likely cause this hypotensive patient to crash

  3. Giving bicarbonate thinking it will "buy time" - It won't address any of the life-threatening problems and adds volume/sodium load 1

  4. Waiting for "definitive indications" - This patient HAS definitive indications: anuria, hyperkalemia, acidosis, uremia, volume overload causing respiratory failure 1

Prognosis Considerations

The combination of septic shock with AKI requiring RRT carries high mortality risk. The markedly elevated BUN (112) relative to creatinine (6.5) - giving a BUN/Cr ratio of approximately 17 - reflects both prerenal azotemia and hypercatabolic state from sepsis 2, 3, 4. This patient will likely require several days of CRRT before renal recovery, if it occurs 5.

The priority is preventing immediate death from hyperkalemia-induced arrhythmia and managing volume overload to improve oxygenation, while providing renal support that doesn't destabilize an already tenuous hemodynamic state.

Related Questions

In a 45-year-old woman with systemic lupus erythematosus (SLE) and lupus nephritis who presented in septic shock with fever, tachycardia, hypotension, and elevated lactate, and who remains hypotensive after adequate fluid resuscitation, what is the best next step in management?
What is the appropriate management plan for a 58-year-old female with a 17-year history of chronic cough after pneumonia, intermittent sputum production, dyspnea on exertion, nicotine dependence with a 48 pack‑year smoking history (currently smoking ~1 pack every two weeks), who is not on inhalers and requires smoking cessation therapy, a short‑acting bronchodilator inhaler, a 14‑day course of nebulized ipratropium bromide, a cough suppressant, a chest radiograph, and glucose monitoring before a corticosteroid injection?
In an 82‑year‑old long‑term‑care resident, how should an elevated BUN and high BUN‑to‑creatinine ratio with otherwise normal laboratory values and slightly low serum osmolality be interpreted?
In an adult with an acute cough from a viral or uncomplicated bacterial respiratory infection, what is the recommended treatment and how do dexamethasone and prednisone compare for short‑course corticosteroid therapy?
In a 24-year-old man with recurrent proximal lower‑limb weakness causing difficulty gripping slippers and rising from a squat, prior episodes fully responsive to steroids but a current steroid‑resistant relapse, and no cranial nerve, sensory, or cerebellar involvement, what is the appropriate diagnostic work‑up and acute management?
How soon should bilirubin be rechecked in an infant on intensive phototherapy, especially if the infant is preterm (<38 weeks gestation) or has high‑risk features?
How many weeks of continuous lisdexamfetamine (Vyvanse) therapy are needed to achieve improvement in emotional regulation?
In a patient with dark yellow-brown urine, what blood tests should be obtained in addition to urine analysis?
What are the indications, dosing schedule, duration limits, contraindications, and precautions for using metoclopramide in adults?
What are the indications, dosing guidelines, contraindications, precautions, and adverse effects of metoclopramide?
What are the best medications for severe panic attacks other than alprazolam (Xanax)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.